• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CODMAN AND SHURTLEFF, INC ENTERPRISE VASCULAR RECONSTRUCTION DEVICE AND DELIVERY SYSTEM; CNV ENTERPRISE SES (NJE)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CODMAN AND SHURTLEFF, INC ENTERPRISE VASCULAR RECONSTRUCTION DEVICE AND DELIVERY SYSTEM; CNV ENTERPRISE SES (NJE) Back to Search Results
Catalog Number ENC452200
Device Problem Inaccurate Delivery (2339)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 12/02/2014
Event Type  malfunction  
Event Description
The contact at the hospital reported that during treatment of an unruptured middle cerebral artery (mca) aneurysm and normal vessel the enterprise stent (enc452200/lot # unknown) could not be placed accurately during deployment.The stent was not implanted at an acute angle, and upon deployment, the stent ¿jumped back¿ 10mm beyond its intended site.To place the stent, the microcatheter was placed distal to the target site, then withdrawn to deploy the device.The device could not be recaptured, removed, or relocated.The stent was implanted in the mca ¿ internal carotid artery (ica) junction with good wall apposition.There was no vessel stenosis.A prowler select plus (details unknown) microcatheter was used in the procedure.The procedure was completed with embolic coils (details unknown) and there was no issue passing other devices through the same microcatheter.An adequate continuous flush was maintained through the catheter.The microcatheter was not reshaped.There was no difficulty during introduction of the microcatheter over the guidewire prior to attempted use of the stent.There was no patient injury or significant clinical delay in the procedure due to the issue.At initial contact the product was not available for return.
 
Manufacturer Narrative
No sterile lot number was reported thus no dhr could be conducted.Stent migration is a known potential adverse event associated with intravascular stent implantation and is listed in the enterprise ifu as such.All products are 100% inspected prior to leaving the manufacturing facility and there is no evidence of a manufacturing related issue.No corrective action is required at this time.Review of the limited information suggests that vessel, target site and procedural issues may have contributed to the reported event.Udi: unknown part number, all 3 attempts to obtain product were unsuccessful, udi unavailable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENTERPRISE VASCULAR RECONSTRUCTION DEVICE AND DELIVERY SYSTEM
Type of Device
CNV ENTERPRISE SES (NJE)
Manufacturer (Section D)
CODMAN AND SHURTLEFF, INC
325 paramount dr
raynham MA
Manufacturer Contact
duane durbin
14700 nw 57th court
miami lakes, FL 33014
5088288310
MDR Report Key4602030
MDR Text Key20119935
Report Number1058196-2015-00062
Device Sequence Number1
Product Code NJE
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
H60001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer,Health Professional,User Facility,Company Representative
Reporter Occupation Other
Type of Report Initial
Report Date 12/15/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/14/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberENC452200
Was Device Available for Evaluation? No
Date Manufacturer Received12/19/2014
Is the Device Single Use? Yes
Type of Device Usage Initial
Removal/Correction NumberN/A
Patient Sequence Number1
-
-